ES2070846T3 - Arn-virus sin reversion. - Google Patents

Arn-virus sin reversion.

Info

Publication number
ES2070846T3
ES2070846T3 ES88121231T ES88121231T ES2070846T3 ES 2070846 T3 ES2070846 T3 ES 2070846T3 ES 88121231 T ES88121231 T ES 88121231T ES 88121231 T ES88121231 T ES 88121231T ES 2070846 T3 ES2070846 T3 ES 2070846T3
Authority
ES
Spain
Prior art keywords
reversion
rna
virus
vaccines
relates
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES88121231T
Other languages
English (en)
Inventor
Carolyn Louise Weeks-Levy
Steven Joseph Mento
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth Holdings LLC
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Application granted granted Critical
Publication of ES2070846T3 publication Critical patent/ES2070846T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/125—Picornaviridae, e.g. calicivirus
    • A61K39/13—Poliovirus
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32611—Poliovirus
    • C12N2770/32622—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32611—Poliovirus
    • C12N2770/32634—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Physical Deposition Of Substances That Are Components Of Semiconductor Devices (AREA)

Abstract

ESTA INVENCION EXPONE UNA TENSION VIRAL RNA ATENUADA QUE TIENE UNA BAJA CANTIDAD DE REPRODUCCION. MAS PARTICULARMENTE ESTA INVENCION EXPONE MAS VACUNAS Y EL USO DE TALES QUE COMPRENDE LAS TENSIONES VIRALES RNA ATENUADAS.
ES88121231T 1988-01-11 1988-12-19 Arn-virus sin reversion. Expired - Lifetime ES2070846T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US14250788A 1988-01-11 1988-01-11

Publications (1)

Publication Number Publication Date
ES2070846T3 true ES2070846T3 (es) 1995-06-16

Family

ID=22500099

Family Applications (1)

Application Number Title Priority Date Filing Date
ES88121231T Expired - Lifetime ES2070846T3 (es) 1988-01-11 1988-12-19 Arn-virus sin reversion.

Country Status (9)

Country Link
EP (1) EP0325768B1 (es)
JP (1) JPH01222774A (es)
AT (1) ATE121779T1 (es)
AU (1) AU2833789A (es)
DE (1) DE3853672T2 (es)
DK (1) DK8789A (es)
ES (1) ES2070846T3 (es)
FI (1) FI890116A (es)
IL (1) IL88731A0 (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5286640A (en) * 1988-01-05 1994-02-15 Almond Jeffrey W Attenuated polioviruses
GB8901093D0 (en) * 1989-01-18 1989-03-15 Almond Jeffrey W Attenuated viruses
US5298416A (en) * 1989-01-18 1994-03-29 British Technology Group Ltd. Attenuated polioviruses
EP0401421B1 (en) * 1989-06-08 1996-01-03 American Cyanamid Company Non-reverting RNA viruses
GB9107563D0 (en) * 1991-04-10 1991-05-29 Macadam Andrew J Thermostable viruses
GB9107552D0 (en) * 1991-04-10 1991-05-29 Macadam Andrew J Attenuated viruses
GB9705669D0 (en) * 1997-03-19 1997-05-07 British Tech Group Attenuated polioviruses
US6853093B2 (en) 2002-12-20 2005-02-08 Lipman Electronic Engineering Ltd. Anti-tampering enclosure for electronic circuitry
US8405506B2 (en) 2010-08-02 2013-03-26 Verifone, Inc. Secure data entry device
US8593824B2 (en) 2010-10-27 2013-11-26 Verifone, Inc. Tamper secure circuitry especially for point of sale terminal

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4719177A (en) * 1981-04-20 1988-01-12 Massachusetts Institute Of Technology Production of complementary DNA representing RNA viral sequences by recombinant DNA methods and uses therefor
JPS59173084A (ja) * 1982-11-30 1984-09-29 インステイチユ−ト・パスツ−ル ポリオウイルスの免疫原性部位よりなるペプチド類及びこれらのペプチド類を暗合化するヌクレオチド配列を含有するｄｎａ類
EP0156299A3 (en) * 1984-03-26 1987-04-01 Chiron Corporation Ltr modified viral vaccines

Also Published As

Publication number Publication date
DE3853672D1 (de) 1995-06-01
DE3853672T2 (de) 1996-01-11
EP0325768A2 (en) 1989-08-02
EP0325768B1 (en) 1995-04-26
EP0325768A3 (en) 1989-08-30
DK8789A (da) 1989-07-12
FI890116A (fi) 1989-07-12
JPH01222774A (ja) 1989-09-06
IL88731A0 (en) 1989-07-31
AU2833789A (en) 1989-07-13
DK8789D0 (da) 1989-01-10
FI890116A0 (fi) 1989-01-10
ATE121779T1 (de) 1995-05-15

Similar Documents

Publication Publication Date Title
NO882873D0 (no) Ikke-gulnende beleggspreparater og deres anvendelse.
GR3034708T3 (en) Retrovirus of the type HIV-2 capable of inducing AIDS, and the antigenic and nucleic acid components thereof.
DE68927025D1 (de) HIV-2-Virusvarianten
LU91152I2 (fr) étanique, d'anatoxine coquelucheuse, d'hémagglutinCombinaison d'anatoxine diphtérique, d'anatoxine tine filamenteuse, de pertactine et de virus poliomyélitique inactivé type 1, type 2 et type 3.
DE3885431D1 (de) Expression der viral kodierten Protease P2A des HRV2.
NZ219002A (en) Method of modifying plant virus by pre-transforming plant genome
ES2070846T3 (es) Arn-virus sin reversion.
NO862975D0 (no) Kvaternaere oksalkylerte polykondensater, fremgangsmaate til deres fremstilling, og deres anvendelse.
NO880473L (no) Fremgangsmaate til fremstilling av substituerte 3,4-dihydro-2h-benzopyraner og deres anvendelse som legemiddel.
DE3650319D1 (de) Klonierung und expression von wirtsschützenden immunogenen des infektioesen bursavirus (ibdv).
DE3879321D1 (de) Bestimmung des aetzungsendpunktes.
DK661288A (da) Iminophenylthiazolidiner, fremgangsmaade til deres fremstilling samt anvendelsen heraf
KR930702527A (ko) gp160의 유도체 및 보조약을 함유하는 gp160 또는 그의 유도체를 기재로하는 백신
ATE132527T1 (de) Nicht-zurückmutierende rna-viren
NO892570D0 (no) Polysilazaner, deres fremstilling og anvendelse.
DE69014100D1 (de) Cdns des orsv-virus gens.
DK26588A (da) 3-methylenspiro-(benzofuranpiperidiner), deres fremstilling og anvendelse samt ved fremstillingen anvendelige mellemprodukter
ATE96839T1 (de) Expression der viral kodierten protease p2a des hrv2.
NO891355D0 (no) Vaksinasjon mot rabis-beslektede virus.
NO903506D0 (no) Distraksjonsapparat for aa opprettholde orientering av brukket ledd.
RO96458A2 (ro) Arzator ceramic termorezistent
SU1739559A1 (ru) Штамм вируса aphtae epizooticae типа o, используемый для изготовления диагностических сывороток и антигенных препаратов

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 325768

Country of ref document: ES